SCHEMBL7403189

SCHEMBL7403189

C=C(Cc1ccccc1)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
MAPK1 P28482 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
TDP1 Q9NUW8 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
CA12 O43570 1/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A3 Q01959 1/20 0.48
KMT2A Q03164 1/20 0.48
TSHR P16473 1/20 0.46
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
AKR1B1 P15121 1/20 0.43
IDO1 P14902 1/20 0.43
PAM P19021 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14530533 0.84 ALDH1A1 (0.52) ALDH1A1MAPK1L3MBTL1TDP1CA1
SCHEMBL9302792 0.83 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1TDP1CA1
SCHEMBL28079753 0.81 ALDH1A1 (0.44) ALDH1A1MAPK1L3MBTL1KMT2ATSHR
SCHEMBL12021626 0.81 ALDH1A1 (0.42) ALDH1A1MAPK1L3MBTL1CA1CA2
SCHEMBL13176595 0.81 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1TDP1CA1
SCHEMBL19057196 0.79 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1TDP1CA1
SCHEMBL4246837 0.79 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1TDP1CA1
SCHEMBL217133 0.79 CES1 (0.48) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL27509184 0.79 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1TDP1CA1
SCHEMBL13069738 0.79 ALDH1A1 (0.47) ALDH1A1MAPK1L3MBTL1TDP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0531382-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-03-17 EP claimed
WO-1991018888-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-12 WO claimed
EP-0531382-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-03-17 EP disclosed
EP-0531382-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-03-17 EP disclosed
WO-1991018888-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-12 WO disclosed
WO-1991018888-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-12 WO disclosed